Combating Illicit Xylazine Act

# Summary of the Combating Illicit Xylazine Act (S 545) **What the Bill Would Do** This bill addresses the growing problem of xylazine, a veterinary sedative that has increasingly been mixed into illegal drugs like fentanyl and heroin. The legislation would create new federal tools to combat the illegal production and distribution of xylazine, likely including tougher criminal penalties for trafficking the substance and increased oversight of how it's manufactured and distributed. The bill would also involve federal agencies in regulating and monitoring xylazine's use outside of legitimate veterinary purposes. **Who It Affects and Key Provisions** The bill primarily affects law enforcement agencies, pharmaceutical manufacturers, veterinary practices, and communities struggling with opioid addiction. Because xylazine can be mixed into street drugs, it impacts people who use illicit substances—often without their knowledge.

The bill targets various aspects of the problem, including manufacturing controls, licensing requirements, and sentencing guidelines for traffickers. It likely coordinates efforts between health regulators and the U.S. Sentencing Commission to ensure consistent enforcement. **Current Status** As of now, the bill remains in committee and has not advanced to a full Senate vote. This means it's still in the early legislative process where it may be debated, modified, or could stall without further action.